Biotech IV Monitor

BLTE — Belite Bio Inc

$6.0B market cap · 2 upcoming readouts tracked

Clinical trial readout dates for Belite Bio Inc, compiled from ClinicalTrials.gov, alongside the SEC filings where results are announced. The next expected readout is June 2027.

Next readoutJune 2027in ~7 months
Upcoming readouts22 Phase 3
Market cap$6.0B

Upcoming readouts

Phase 3 Tinlarebant
Geographic Atrophy · NCT05949593
June 2027
Ongoing
Phase 2/3 Tinlarebant
STGD1; Stargardt Disease 1 · NCT06388083
February 2028
Ongoing

Companies working on similar indications

Discussion

No messages yet. If you follow BLTE, you can start the conversation.
Track BLTE in real time
See live implied volatility for BLTE and 106 other biotechs, and get alerted when a readout lands.
🔔 Alert me on BLTE
Contact — questions or corrections about BLTE: dukeupt@gmail.com